sertraline has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, CB; Kim, HM; Martis, B; Norman, SB; Rauch, SAM; Simon, NM; Stein, MB; Tripp, JC; Venners, MR | 1 |
| Duax, JM; Feeny, NC; Jaeger, J; Marks, EH; Walker, RSW; Zoellner, LA | 1 |
| Christensen, JP; Daldorph, E; Kromann, S; Kudirkiene, E; Li, L; Meng, H; Olsen, RH; Thoefner, I | 1 |
| Pradhan, BK; Tobe, E | 1 |
| Fleischhacker, WW; Hofer, A; Hummer, M | 1 |
| Clary, CM; Harvey, AT; Kornstein, SG; Silkey, BS | 1 |
| Cadet, JL; Duan, W; Ford, E; Ladenheim, B; Masuda, N; Peng, Q; Ross, CA; Tryggestad, E; Wong, J; Zhao, M | 1 |
2 trial(s) available for sertraline and Disease Exacerbation
| Article | Year |
|---|---|
Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Disease Progression; Female; Humans; Implosive Therapy; Male; Medication Therapy Management; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2020 |
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status.
Topics: Adult; Cross-Over Studies; Depressive Disorder, Major; Disease Progression; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Menopause; Middle Aged; Patient Dropouts; Sertraline; Sex Factors; Treatment Outcome | 2007 |
5 other study(ies) available for sertraline and Disease Exacerbation
| Article | Year |
|---|---|
Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD.
Topics: Adult; Adult Survivors of Child Abuse; Child; Child Abuse; Child Abuse, Sexual; Depressive Disorder, Major; Disease Progression; Female; Humans; Implosive Therapy; Male; Mental Disorders; Middle Aged; Patient Dropouts; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2020 |
Treatment with high-dose antidepressants severely exacerbates the pathological outcome of experimental Escherichia coli infections in poultry.
Topics: Animals; Antidepressive Agents; Body Weight; Chickens; Colony Count, Microbial; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fallopian Tubes; Female; Immunohistochemistry; Liver; Poultry Diseases; Sertraline; Tetracycline | 2017 |
Limiting progressive hippocampal metabolic abnormalities after smoke inhalation injury.
Topics: Brain Diseases, Metabolic; Disease Progression; Glucose; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoke Inhalation Injury | 2014 |
Worsening of psychosis after replacement of adjunctive valproate with topiramate in a schizophrenia patient.
Topics: Adult; Anticonvulsants; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fructose; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Sertraline; Topiramate; Valproic Acid | 2003 |
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.
Topics: Animals; Asparagine; Cell Differentiation; Cell Movement; Disease Models, Animal; Disease Progression; Glutamine; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Sertraline | 2008 |